Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
|
|
Fuss Brands Corp. (CBP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/04/2010 |
8-K
| Investor presentation|
Docs:
|
"Renhuang Announces Fiscal Year 2010 Guidance · Expect 26% to 28% revenue and net income growth Harbin, China – March 04, 2010 – Renhuang Pharmaceuticals, Inc. , a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines in China, today announced revenue and net income guidance for fiscal year 2010 ending October 31, 2010. Renhuang expects revenues for FY 2010 to be in the range of $54.7-$55.6 million, which represents a 26% to 28% increase over reported revenues of $43.4 million in fiscal year 2009. The Company expects FY 2010 net income to be in the range of $18.6-$18.9 million, up 26% to 28% from net income of $14.8 million in fiscal year 2009. “We anticipate strong organic growth in the top- and bottom-line to be driven by our ...",
"Copy of Company Presentation" |
|
|
|